SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

29 May 2024 Evaluate
The company's total revenue for the quarter ended March 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 2058.00 millions.The Total Profit for the quarter ended March 2024 of Rs. 325.00 millions grew from Rs.-308.00 millionsThe company reported a good operating profit of 623.00 millions compared to 158.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2058.00 1998.00 3.00 7847.00 8101.00 -3.14 7847.00 8101.00 -3.14
Other Income 501.00 137.00 265.69 1034.00 1379.00 -25.02 1034.00 1379.00 -25.02
PBIDT 623.00 158.00 294.30 1199.00 1410.00 -14.96 1199.00 1410.00 -14.96
Interest 81.00 57.00 42.11 299.00 185.00 61.62 299.00 185.00 61.62
PBDT 542.00 101.00 436.63 900.00 1225.00 -26.53 900.00 1225.00 -26.53
Depreciation 127.00 113.00 12.39 483.00 432.00 11.81 483.00 432.00 11.81
PBT 415.00 -12.00 -3558.33 417.00 793.00 -47.41 417.00 793.00 -47.41
TAX 90.00 296.00 -69.59 101.00 294.00 -65.65 101.00 294.00 -65.65
Deferred Tax 22.00 302.00 -92.72 33.00 156.00 -78.85 33.00 156.00 -78.85
PAT 325.00 -308.00 -205.52 316.00 499.00 -36.67 316.00 499.00 -36.67
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 30.27 7.91 282.81 15.28 17.41 -12.21 15.28 17.41 -12.21

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×